Race, ABO blood group, and venous thromboembolism risk: Not black and white

Transfusion

Volumn 53, Issue 1, 2013, Pages 187-192

  Fang, Chunhui ^b   Cohen, Hillel W ^b   Billett, Henny H ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS ANTIGEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BLOOD GROUP ABO SYSTEM; BLOOD GROUP RHESUS SYSTEM; CAUCASIAN; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COMORBIDITY; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; OUTCOME ASSESSMENT; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; VENOUS THROMBOEMBOLISM;

ABO BLOOD-GROUP SYSTEM; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VENOUS THROMBOEMBOLISM;

EID: 84872267142     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2012.03665.x     Document Type: Article

References (33)

1. White RH,. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
2. Anderson FA Jr, Spencer FA,. Risk factors for venous thromboembolism. Circulation 2003; 107: I-9-16.
3. Keenan CR, White RH,. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med 2007; 13: 377-83.
4. White RH, Dager WE, Zhou H, Murin S,. Racial and gender differences in the incidence of recurrent venous thromboembolism. Thromb Haemost 2006; 96: 267-73.
5. Holst AG, Jensen G, Prescott E,. Risk factors for venous thromboembolism: results from the Copenhagen City Heart Study. Circulation 2010; 121: 1896-903.
6. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, Hillege HL, van der Meer J,. Microalbuminuria and risk of venous thromboembolism. JAMA 2009; 301: 1790-7.
7. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR,. Cardiovascular risk factors and venous thromboembolism incidence: the Longitudinal Investigation of Thromboembolism Etiology. Arch Intern Med 2002; 162: 1182-9.
8. White RH, Zhou H, Murin S, Harvey D,. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 2005; 93: 298-305.
9. White RH, Zhou H, Romano PS,. Incidence of idiopathic deep venous thrombosis and secondary thromboembolism among ethnic groups in California. Ann Intern Med 1998; 128: 737-40.
10. Spencer FA, Emery C, Lessard D, Anderson F, Emani S, Aragam J, Becker RC, Goldberg RJ,. The Worcester Venous Thromboembolism study: a population-based study of the clinical epidemiology of venous thromboembolism. J Gen Intern Med 2006; 21: 722-7.
11. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd,. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 1998; 158: 585-93.
12. White RH, Keenan CR,. Effects of race and ethnicity on the incidence of venous thromboembolism. Thromb Res 2009; 123 Suppl 4: S11-7.
13. Ohira T, Cushman M, Tsai MY, Zhang Y, Heckbert SR, Zakai NA, Rosamond WD, Folsom AR,. ABO blood group, other risk factors and incidence of venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology. J Thromb Haemost 2007; 5: 1455-61.
14. Morelli VM, De Visser MC, Vos HL, Bertina RM, Rosendaal FR,. ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden. J Thromb Haemost 2005; 3: 183-5.
15. Edgren G, Hjalgrim H, Rostgaard K, Norda R, Wikman A, Melbye M, Nyrén O,. Risk of gastric cancer and peptic ulcers in relation to ABO blood type: a cohort study. Am J Epidemiol 2010; 172: 1280-5.
16. Wolpin BM, Chan AT, Hartge P, Chanock SJ, Kraft P, Hunter DJ, Giovannucci EL, Fuchs CS,. ABO blood group and the risk of pancreatic cancer. J Natl Cancer Inst 2009; 101: 424-31.
17. Trégouët D-A, Heath S, Saut N, Biron-Andreani C, Schved J-F, Pernod G, Galan P, Drouet L, Zelenika D, Juhan-Vague I, Alessi MC, Tiret L, Lathrop M, Emmerich J, Morange PE,. Common susceptibility alleles are unlikely to contribute as strongly as the FV and ABO loci to VTE risk: results from a GWAS approach. Blood 2009; 113: 5298-303.
18. Clark P, Walker ID, Govan L, Wu O, Greer IA,. The GOAL study: a prospective examination of the impact of factor V Leiden and ABO(H) blood groups on haemorrhagic and thrombotic pregnancy outcomes. Br J Haematol 2008; 140: 236-40.
19. Larsen TB, Johnsen SP, Gislum M, Moller CA, Larsen H, Sorensen HT,. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005; 3: 300-4.
20. Wu O, Bayoumi N, Vickers MA, Clark P,. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6: 62-9.
21. Streiff MB, Segal J, Grossman SA, Kickler TS, Weir EG,. ABO blood group is a potent risk factor for venous thromboembolism in patients with malignant gliomas. Cancer 2004; 100: 1717-23.
22. Garratty G, Glynn SA, McEntire R,. ABO and Rh(D) phenotype frequencies of different racial/ethnic groups in the United States. Transfusion 2004; 44: 703-6.
23. Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR,. Plasma hemostatic factors and endothelial markers in four racial/ethnic groups:the MESA study. J Thromb Haemost 2006; 4: 2629-35.
24. Westhoff CM,. The structure and function of the Rh antigen complex. Semin Hematol 2007; 44: 42-50.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83.
26. Gallinaro L, Cattini MG, Sztukowska M, Padrini R, Sartorello F, Pontara E, Bertomoro A, Daidone V, Pagnan A, Casonato A,. A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor. Blood 2008; 111: 3540-5.
27. O'Donnell J, Boulton FE, Manning RA, Laffan MA,. Amount of H antigen expressed on circulating von Willebrand factor is modified by ABO blood group genotype and is a major determinant of plasma von Willebrand factor antigen levels. Arterioscler Thromb Vasc Biol 2002; 22: 335-41.
28. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Tracy RP, Aleksic N, Folsom AR,. Coagulation factors, inflammation markers, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE). Am J Med 2002; 113: 636-42.
29. Folsom AR, Cushman M, Tsai MY, Aleksic N, Heckbert SR, Boland LL, Tsai AW, Yanez ND, Rosamond WD,. A prospective study of venous thromboembolism in relation to factor V Leiden and related factors. Blood 2002; 99: 2720-5.
30. Ruiz-Narváez EA, Rosenberg L, Wise LA, Reich D, Palmer JR,. Validation of a small set of ancestral informative markers for control of population admixture in African Americans. Am J Epidemiol 2011; 173: 587-92.
31. Tandon A, Patterson N, Reich D,. Ancestry informative marker panels for African Americans based on subsets of commercially available SNP arrays. Genet Epidemiol 2011; 35: 80-3.
32. Chen GS, Zhou J, Doumatey A, Huang H, Gerry NP, Herbert A, Christman MF, Chen Y, Dunston GM, Faruque MU, Rotimi CN, Adeyemo A,. Development of admixture mapping panels for African Americans from commercial high-density SNP arrays. BMC Genomics 2010; 11: 417.
33. Pinkhasov RM, Wong J, Kashanian J, Lee M, Samadi DB, Pinkhasov MM, Shabsigh R,. Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States. Int J Clin Pract 2010; 64: 475-87.